TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
VNDA

Vanda Pharmaceuticals Inc

Healthcare · Biotechnology

5.10$ +1.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Vanda Pharmaceuticals Inc (VNDA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 412 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VNDA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
642 648 653 651 645 656 632 625 601 489 434 412
537 433 439 439 432 439 408 395 367 347 293 264
183 136 125 103 100 102 112 81 70 85 54 56
490 388 394 388 376 375 341 326 294 264 202 170
29 34 37 42 43 47 45 45 51 55 57 60
1.0 1.4 1.5 1.5 1.6 1.7 1.9 2.2 2.0 1.9 1.7 1.7
17 121 119 118 116 114 112 111 109 117 115 113
99 104 109 109 104 118 121 138 135 162 153 192
85 88 93 94 89 100 104 121 118 145 136 164
2.4 2.4 2.4 2.4 2.5 4.3 4.4 4.7 4.7 5.6 6.0 4.6
3.5 7.1 6.6 3.8 5.8 3.5 6.0 2.2 3.1 4.9 4.5 8.7
543 545 544 543 541 539 511 486 466 327 281 220
-153 -155 -160 -164 -169 -174 -204 -231 -254 -395 -443 -506
58 58 58 58 58 58 59 59 59 59 59 60

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?